V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)
Clinical trial NCT00411749 · COMPLETED
Trial details
- NCT number
- NCT00411749
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-11
- Primary completion
- 2009-09-18
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.